| A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment (NCT05537142) | BioVersys AG | 2022-09-02 |
| A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression (NCT05268497) | Janssen Research & Development, LLC | 2022-09-01 |
| NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab (NCT04211675) | Nationwide Children's Hospital | 2022-09-01 |
| Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells (NCT05214014) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-09-01 |
| Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation (NCT05470465) | Food and Drug Administration (FDA) | 2022-09-01 |
| Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers. (NCT05285696) | Cytosite Biopharma Inc. | 2022-09-01 |
| A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors (NCT05516914) | Nanjing Leads Biolabs Co.,Ltd | 2022-09-01 |
| Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL (NCT05495035) | Institute of Hematology & Blood Diseases Hospital, China | 2022-09-01 |
| Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery (NCT04585620) | Allan Vestergaard Danielsen, MD | 2022-09-01 |
| Oral Paclitaxel for Patients with Advanced Solid Tumors (NCT06589401) | InnoUp Farma S.L. | 2022-09-01 |
| Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis (NCT04709458) | Taiga Biotechnologies, Inc. | 2022-09-01 |
| Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC (NCT05533892) | Wan-Guang Zhang | 2022-09-01 |
| Topical Antibacterial Agents for Prevention of COVID-19 (NCT05449392) | Yale University | 2022-09-01 |
| COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI (NCT05790902) | Armed Forces Institute of Urology, Rawalpindi | 2022-09-01 |
| A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab (NCT05378425) | Nectin Therapeutics Ltd | 2022-09-01 |
| ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9 (NCT05224505) | Atamyo Therapeutics | 2022-09-01 |
| Intranasal Human FGF-1 for Subjects With Parkinson's Disease (NCT05493462) | Zhittya Genesis Medicine, Inc. | 2022-09-01 |
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application (NCT05458544) | FutureChem | 2022-09-01 |
| Transversus Abdominis Plane Blocks With and Without Dexamethasone (NCT05432934) | University of Saskatchewan | 2022-09-01 |
| PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites (NCT05501340) | Second Affiliated Hospital of Soochow University | 2022-09-01 |
| A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants (NCT05537090) | BioVersys AG | 2022-09-01 |
| Hepatocyte Microbeads for Acute Liver Failure (NCT05491135) | King's College Hospital NHS Trust | 2022-09-01 |
| Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors (NCT05533697) | ModernaTX, Inc. | 2022-09-01 |
| A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers (NCT05568121) | Celltrion | 2022-09-01 |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction (NCT05445921) | Washington University School of Medicine | 2022-09-01 |
| Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy (NCT05276284) | Kristoffer Rohrberg | 2022-09-01 |
| BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (NCT05376345) | Shanghai Changzheng Hospital | 2022-09-01 |
| Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers (NCT05417425) | Omeza, LLC | 2022-09-01 |
| IMM40H Phase I Dose Escalation and Expansion (NCT05549557) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-09-01 |
| Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC (NCT05842317) | Peking Union Medical College Hospital | 2022-09-01 |
| Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers (NCT05974982) | Jinnah Postgraduate Medical Centre | 2022-09-01 |
| TNFα Monoclonal Antibody for Acute Spinal Cord Injury (NCT04988425) | Shanghai Changzheng Hospital | 2022-09-01 |
| Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis (NCT05521022) | Attralus, Inc. | 2022-09-01 |
| Treating Chronic Cervicogenic Head and Neck Pain (NCT05617365) | Michigan State University | 2022-09-01 |
| Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva (NCT06437262) | University of Santiago de Compostela | 2022-09-01 |
| Remote Mindfulness Training Following Early Life Adversity (NCT05516108) | University of Pittsburgh | 2022-09-01 |
| Anlotinib Hydrochloride Capsule Monotherapy and Combination Therapy Relapsed and Refractory Multiple Myeloma (NCT05549973) | Institute of Hematology & Blood Diseases Hospital, China | 2022-09-01 |
| Evaluation of Smoked THC and CBD in Men and Women (NCT05037487) | University of California, Los Angeles | 2022-09-01 |
| A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors (NCT05501912) | ABM Therapeutics Shanghai Company Limited | 2022-09-01 |
| Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian Cancer (NCT05270720) | West China Second University Hospital | 2022-09-01 |
| Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer (NCT05574881) | Fudan University | 2022-09-01 |
| Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC (NCT05155124) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-09-01 |
| Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment (NCT05289804) | University of Dublin, Trinity College | 2022-09-01 |
| SBRT With Atezo/Bev for HCC (NCT05488522) | Abramson Cancer Center at Penn Medicine | 2022-09-01 |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC (NCT05191017) | Nuvation Bio Inc. | 2022-09-01 |
| LEAC-102 for Advanced Colorectal Cancer (NCT02826837) | Taiwan Leader Biotech Corp. | 2022-09-01 |
| Phase 1 Study of ATRS-2002 in Healthy Male Adults (NCT04879589) | Syneos Health | 2022-09-01 |
| Cryopreserved MMUD BM With PTCy for Hematologic Malignancies (NCT05170828) | Ossium Health, Inc. | 2022-09-01 |
| Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections (NCT05269121) | Adaptive Phage Therapeutics, Inc. | 2022-09-01 |
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC (NCT05191004) | Nuvation Bio Inc. | 2022-09-01 |
| Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer (NCT05507593) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-01 |
| Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance. (NCT05279768) | PT. Prodia Stem Cell Indonesia | 2022-09-01 |
| A Dose Escalation Phase 1 Study Evaluating the Safety and Pharmacokinetics of an Inhaled COVID-19 Inhibitor Delcetravir in Healthy Subjects (NCT05453279) | Esfam Biotech Pty Ltd | 2022-09-01 |
| Ethoximod Pharmacokinetics In Healthy Subjects (NCT06361212) | Longevity Inc. | 2022-09-01 |
| Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer (NCT05508906) | Olema Pharmaceuticals, Inc. | 2022-08-31 |
| FMT to Convert Response to Immunotherapy (NCT05251389) | The Netherlands Cancer Institute | 2022-08-31 |
| A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants (NCT05515601) | Eli Lilly and Company | 2022-08-31 |
| BAY2586116 Nasal Spray and OSA Severity (NCT05527457) | Flinders University | 2022-08-31 |
| Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer (NCT05386108) | Stemline Therapeutics, Inc. | 2022-08-31 |
| Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM (NCT07150104) | GlaxoSmithKline | 2022-08-31 |
| Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants (NCT05525910) | Pfizer | 2022-08-31 |
| A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma (NCT05273554) | M.D. Anderson Cancer Center | 2022-08-31 |
| 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) (NCT04315246) | Y-mAbs Therapeutics | 2022-08-31 |
| Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. (NCT04118868) | Sorrento Therapeutics, Inc. | 2022-08-31 |
| Memesto Wearable Device for Persons With Dementia (NCT05153161) | Edgewater Safety Systems, Inc. | 2022-08-31 |
| Treatment of a Single Patient With CRD-TMH-001 (NCT05514249) | Cure Rare Disease, Inc | 2022-08-31 |
| Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma (NCT05460767) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-08-31 |
| A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users. (NCT05587998) | AstraZeneca | 2022-08-31 |
| Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma (NCT05083754) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-08-31 |
| Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations (NCT05810740) | Pierre Fabre Medicament | 2022-08-31 |
| A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects (NCT05655221) | Tasly Biopharmaceuticals Co., Ltd. | 2022-08-30 |
| Selective Neck Dissection Under Multimodal Assessment for N3 Nasopharyngeal Carcinoma After Radiotherapy (NCT07636499) | Guiquan Zhu | 2022-08-30 |
| Study of HR20013 for Injection in Patients With Malignant Solid Tumors (NCT05465681) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2022-08-30 |
| BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease (NCT05456880) | Beam Therapeutics Inc. | 2022-08-30 |
| A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines (NCT05496335) | AbbVie | 2022-08-30 |
| FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors (NCT05522309) | Etern BioPharma (Shanghai) Co., Ltd | 2022-08-30 |
| Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors (NCT05394103) | Qurient Co., Ltd. | 2022-08-30 |
| Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia (NCT02533232) | Pakistan Institute of Living and Learning | 2022-08-30 |
| A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors (NCT05549804) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2022-08-30 |
| Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease (NCT05586152) | Invirsa, Inc. | 2022-08-30 |
| A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis (NCT05383378) | selectION Therapeutics GmbH | 2022-08-30 |
| A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia (NCT05463770) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-08-30 |
| The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients (NCT05496179) | Ain Shams University | 2022-08-30 |
| First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies (NCT05348889) | Chimagen Biosciences, Ltd | 2022-08-30 |
| Safety and Tolerability of EO2002 (NCT05587205) | Asociación para Evitar la Ceguera en México | 2022-08-30 |
| A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers (NCT05787873) | Samik Pharmaceutical Co. Ltd. | 2022-08-30 |
| Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease (NCT05534321) | Baptist Health South Florida | 2022-08-29 |
| A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216. (NCT05506007) | Dong-A ST Co., Ltd. | 2022-08-29 |
| TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88) (NCT05525455) | Teon Therapeutics, Inc. | 2022-08-29 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4 (NCT06548815) | Gan and Lee Pharmaceuticals, USA | 2022-08-29 |
| A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma (NCT05341557) | Betta Pharmaceuticals Co., Ltd. | 2022-08-29 |
| A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants (NCT05482308) | Pfizer | 2022-08-29 |
| Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma (NCT06044506) | Dr Cipto Mangunkusumo General Hospital | 2022-08-29 |
| A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction (NCT05510245) | Pfizer | 2022-08-29 |
| Comparison of Hemodynamic Changes With Morphine Versus Esmolol During Induction of Anaesthesia (NCT06065956) | Pakistan Navy Station Shifa Hospital | 2022-08-28 |
| DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer (NCT05504707) | H. Lee Moffitt Cancer Center and Research Institute | 2022-08-26 |
| Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers (NCT05525780) | G2GBio, Inc. | 2022-08-26 |
| Single Dose Study To Study The Absorption, Metabolism And Excretion Of Famitinib (NCT05473468) | Jiangsu HengRui Medicine Co., Ltd. | 2022-08-26 |
| Study of Orally Administered BEBT-503 in Healthy Subjects (NCT05391880) | BeBetter Med Inc | 2022-08-26 |
| H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC (NCT05552781) | RedCloud Bio | 2022-08-26 |